Mitchell | Genex | Coventry
- Home
- Mitchell | Genex | Coventry
More Stories by This Author
Workers' Comp
Blog
Jurisdictional Rules and Opioid Impacts in 2019
With a continued focus on the harmful effects of the opioid epidemic, oversight of opioid prescribing and monitoring of use through state laws, regulations, guidance, and policies have become commonplace in workers’ comp. Here we’ll examine some of the jurisdictional trends impacting opioids from 2019.
Workers' Comp
Blog
Top 5 Opioid Medication Trends in 2019
2019 yielded another year of declines in both opioid utilization and cost. The top 5 opioid medications comprise the majority of all opioid scripts and cost, and their activity can offer further insight into the favorable trends experienced among this impactful therapeutic class.
Workers' Comp
Blog
Brand and Generic Medication Trends
In this final post related to our in-network and out-of-network analysis we are taking a closer look at brand and generic medication trends in workers’ comp. Stay tuned for more posts addressing specific trends highlighted in the next piece of our drug trends series focusing on opioids.
Workers' Comp
Blog
Top Therapeutic Classes by Age of Claim in 2019
Today we are going to take a deeper dive into Coventry’s Drug Trends by focusing on the influence of claim age as it relates to overall use of prescription drug classes. The data covered here reflects all mail order and retail transactions paid in 2019.
Workers' Comp
Blog
Aggregate Trends for Top 10 Therapeutic Classes in 2019
In 2019, the top 10 therapeutic classes accounted for 76.8% of all scripts and 79.6% of all costs.
Workers' Comp
Blog
Specialty Drugs' Impact on Overall Costs in 2019
First Script overall prescription trends saw a slight upward shift in 2019. We’ll take a closer look at some of the specialty medication classes and specific drugs driving this shift and their impacts on overall costs, such as those from the hematological class, HIV medications, and one novel topical eye disorder treatment.